GlassScriptPhysician profile
Anetta Remelski
NPI 1861162448
$2,637.20
in general payments reported to CMS, 2019-2025
29 companies · $919 in 2025
The $919 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $694 · 2023: $530 · 2024: $494 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,041.69 | 2022-2025 | Wegovy |
| Lilly USA, LLC | $266.22 | 2022-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $157.28 | 2022-2024 | Trelegy Ellipta, Shingrix |
| Biotissue Holdings INC. | $138.58 | 2025 | |
| Dexcom, INC. | $121.54 | 2025 | Dexcom G6 Transmitter |
| Scilex Pharmaceuticals INC. | $114.29 | 2024-2025 | |
| Pfizer INC. | $101.20 | 2022-2025 | |
| Abbvie INC. | $95.05 | 2022-2024 | |
| Exact Sciences Corporation | $73.07 | 2023-2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $68.06 | 2024-2025 | Ams 700, Watchman Flx |
| Daiichi Sankyo INC. | $56.20 | 2022-2023 | Injectafer |
| Intra-Sana Laboratories | $45.22 | 2022-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.09 | 2024 | Trulance, Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $31.55 | 2022 | |
| Currax Pharmaceuticals LLC | $29.05 | 2025 | Contrave |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $28.58 | 2025 | Prospera |
| Asensus Surgical, INC. | $26.51 | 2022 | |
| Inspire Medical Systems, INC. | $21.03 | 2025 | Inspire |
| Astellas Pharma US INC | $20.05 | 2025 | Veozah |
| Xeris Pharmaceuticals, INC. | $19.53 | 2024 | Gvoke Hypopen |
| Bausch Health US, LLC | $18.68 | 2025 | Aplenzin |
| Phadia US INC. | $18.32 | 2022 | |
| Invivyd INC | $18.00 | 2025 | Pemgarda |
| Philips North America LLC | $17.77 | 2024 | (Ck7) Extended Holter |
| Intuity Medical INC | $17.29 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Alkermes, INC. | $17.01 | 2025 | Vivitrol |
| Merck Sharp & Dohme LLC | $16.96 | 2023 | Steglatro |
| Takeda Pharmaceuticals U.S.A., INC. | $14.40 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anetta Remelski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.